OakChart

Integer Holdings Corp

ITGRHealthcare·Medical Devices·USA·Mid·NYSE·Nov 11 • 10:10 AM ET

126.64+0.02 (0.01%)
2026-11-11 16:11 CET
Market cap
4,304.74 USD m
Revenue, TTM
1,821.49 USD m
Net income, TTM
103.70 USD m
Free cash flow, TTM
81.82 USD m
EPS diluted, TTM
2.99
P/E
42.40
Compare

Price

ITGR against its 20, 50 and 200-day averages
2050200miss
90.00100.00110.00120.006.3M12.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ITGRclose 126.6420-day 126.6250-day 126.42200-day 102.44126.64

0.2% under 126.83 on 20 Oct 2026. Last 15 sessions, 0.2% high to low

Profile

ITGR
52-week range, 100% of the way up
66.51126.83

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.

IndexRUT
Employees11000
IPOSep 29, 2000
Beta0.58
ATR, 14d0.20
Rel volume0.52
Short float11.82%
Insider own14.60%
Inst own117.07%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.31B
Enterprise Value5.64B
Income103.70M
Sales1.82B
Book/sh50.78
Cash/sh0.42
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees11000
IPOSep 29, 2000

Ratios

P/E42.40
Forward P/E18.60
PEG-
P/S2.36
P/B2.49
P/C304.69
P/FCF52.62
EV/EBITDA18.55
EV/Sales3.09
Quick Ratio2.60
Current Ratio3.98
Debt/Eq0.78
LT Debt/Eq0.77
Option/ShortYes / Yes

Earnings

EPS (ttm)2.99
EPS next Y6.81
EPS next Q1.60
EPS this Y-6.72%
EPS next Y14.07%
EPS next 5Y-
EPS past 3/5Y13.83% 4.37%
Sales past 3/5Y10.24% 11.47%
EPS Y/Y TTM20.67%
Sales Y/Y TTM-0.33%
EPS Q/Q-61.16%
Sales Q/Q-3.63%
EarningsOct 29 BMO
EPS/Sales Surpr.-20.30% -1.59%

Ownership

Insider Own14.60%
Insider Trans-0.82%
Inst Own117.07%
Inst Trans5.47%
ROA3.05%
ROE5.97%
ROIC3.39%
Gross Margin22.09%
Oper. Margin9.03%
Profit Margin5.69%
SMA200.01%
SMA500.17%
SMA20023.62%
Trades-

Technical

Shs Outstand34.00M
Shs Float29.04M
Short Float11.82%
Short Ratio4.17
Short Interest3.43M
52W High126.83 -0.15%
52W Low66.51 90.40%
Volatility0.15% 0.12%
ATR (14)0.20
RSI (14)59.92
Beta0.58
Rel Volume0.52
Avg Volume822.87K
Volume62,681

Performance

Perf Week-0.00%
Perf Month0.04%
Perf Quarter1.26%
Perf Half Y41.67%
Perf YTD61.46%
Perf Year81.37%
Perf 3Y49.63%
Perf 5Y43.12%
Perf 10Y396.61%
Recom3.20
Target Price127.00
Prev Close126.62
Price126.64
Change %0.01%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 13, 2026UpgradeOOppenheimerPerform → Outperform$115-9.2%
Feb 20, 2026UpgradeTThe Benchmark CompanyHold → Buy$95-25.0%
Oct 24, 2025DowngradeWWells FargoOverweight → Equal Weight$80-36.8%
Oct 24, 2025DowngradeTThe Benchmark CompanyBuy → Hold
Oct 24, 2025DowngradeCCitigroupBuy → Neutral$77-39.2%
Oct 24, 2025DowngradeBBofA SecuritiesBuy → Neutral$87-31.3%
Oct 24, 2025DowngradeAArgusBuy → Hold
May 22, 2025UpgradeCCitigroupNeutral → Buy$140+10.6%
Mar 28, 2025InitiatedRRaymond JamesOutperform$145+14.5%
Feb 21, 2025DowngradeOOppenheimerOutperform → Perform

Peers

Mkt cap
TickerCompanyMkt cap
UFPTUFP Technologies Inc2.42B
LIVNLivaNova PLC4.97B
BSXBoston Scientific Corp64.92B
MDTMedtronic Plc128.35B
MMSIMerit Medical Systems Inc5.25B
TFXTeleflex Incorporated6.14B
ABTAbbott Laboratories190.10B
SANMSanmina Corp8.55B
JBLJabil Inc26.74B
FLEXFlex Ltd29.54B

Insider trading

12 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Thor Kirk KChief Human Resources OfficerSep 14 '26Sale126.2519,7732,496,43018,920Sep 16 08:33 PM
Thor Kirk KChief Human Resources OfficerSep 15 '26Sale126.2311,7671,485,2957,153Sep 16 08:33 PM
Thor Kirk KOfficerSep 15 '26Proposed Sale126.304,700593,610Sep 15 04:44 PM
Thor Kirk KOfficerSep 11 '26Proposed Sale126.2031,5403,980,348Sep 11 04:26 PM
Senn AndrewPresident, Growth & InnovationSep 08 '26Sale126.309,4081,188,2305,405Sep 10 04:32 PM
Senn AndrewOfficerSep 08 '26Proposed Sale126.309,4081,188,230Sep 08 09:54 AM
Stephens JimPresident, CRM & NeuroMay 15 '26Option Exercise0.001,96306,331May 19 04:28 PM
Smith DironEVP, Chief Financial OfficerMay 08 '26Option Exercise0.002,063013,422May 12 06:00 PM
Thomas Tommy PVP, Corporate ControllerMar 13 '26Sale85.0082570,1254,381Mar 17 05:15 PM
BAILEY PAMELA GDirectorJan 02 '26Option Exercise48.432,883139,62456,052Jan 05 07:29 PM
MAXWELL MARTIN CDirectorDec 12 '25Option Exercise48.432,883139,62425,053Dec 16 07:20 PM
Harris John AEVP, Global Ops and ManufacturNov 12 '25Buy70.001,650115,5006,066Nov 13 04:18 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IJSiShares S&P Small-Cap 600 Value ETFAUM: 7.74B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 206
  • Integer: Q3 Earnings Snapshot (Associated Press)
  • Integer Holdings Corporation Reports Third Quarter 2026 Results (GlobeNewswire)
  • Integer Holdings Corporation Stockholders Approve Proposals in Connection with KKR's Proposed Acquisition of Integer (GlobeNewswire)
  • Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 (GlobeNewswire)
  • Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR (GlobeNewswire)
  • Loading…
  • Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are MG, ITGR, UTZ Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are UTZ, ITGR, FULC Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are ITGR, VREX, HZO, SYNA Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • INTEGER HOLDINGS: Kaskela Law Announces Probe into Adequacy of $127.00 Per Share Buyout Price - Fair or Inadequately Low for the Company's Shareholders? (Business Wire)
  • Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders? (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-291.3401.6810.430449.66456.917
2026Q22026-08-031.6001.3790.691464.11451.078
2026Q12026-04-301.2001.1850.479439.58426.488
2025Q42026-02-191.7601.6991.383472.06462.738
2025Q32025-10-231.7901.6881.114467.69466.458
2025Q22025-07-241.5501.5491.036476464.378
2025Q12025-04-241.3101.234-0.664437.39428.668
2024Q42025-02-201.4301.4590.902449.5446.797
2024Q32024-10-241.4301.3620.990431.42440.597
2024Q22024-07-251.3001.2280.879436.24378
2024Q12024-04-251.1401.1130.586414.81412.787
2023Q42024-02-151.3901.3330.776413.15407.696
2023Q32023-10-261.2701.0990.807404.69376.75
2023Q22023-07-271.1401.0010.712400366.996
2023Q12023-04-270.8700.8330.389378.79352.434
2022Q42023-02-161.1101.0600.511372.42361.252

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY3.8003.482-0.8401,2151,252
2019FY4.6804.3332.7651,2581,254
2020FY2.7702.3272.3331,0731,068
2021FY4.0803.7502.7971,2211,216
2022FY3.8803.8371.9591,3761,365
2023FY4.6704.6182.7211,5971,591
2024FY5.3005.3363.3861,7171,718
2025FY6.4006.3382.8901,8541,845
2026FY-5.970--1,814
2027FY-6.810--1,892
2028FY-7.310--2,036
2029FY-8.560--2,226

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-11301460.87457.3465.3
2026Q4S2026-11-04801463.92456.2469.52
2026Q4S2026-10-30800465.6456.2470.8
2026Q4S2026-10-29800465.79456.2470.8
2026Q4S2026-10-26800465.79456.2470.8
2026Q4S2026-10-17801465.79456.2470.8
2026Q4S2026-08-12802465.79456.2470.8
2026Q4S2026-08-08701466.4456.2470.8
2026Q4S2026-08-03901467.34456.2482
2026Q4S2026-07-21900468.66459.19482
2026Q4S2026-07-14800468.73459.19482
2026Q4S2026-07-08808468.73459.19482
2026Q4S2026-04-30909469.13459.19482
2026Q4S2026-02-20911484.83472.52493

Estimate history

EPS, annual2.08-0.842.7652.3332.7971.9592.7213.3862.892.9866
Period201720182019202020212022202320242025TTM
EPS, quarterly0.990.902-0.6641.0361.1141.3830.4790.6910.433
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1134.7531215.771259.4281072.8241221.7531378.1691554.7261719.8491846.4661821.49
Period201720182019202020212022202320242025TTM
Sales, quarterly430.515452.032436.167472.831466.573470.895441.103459.879449.616
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual31.87132.47332.732.90833.06333.1733.3333.54634.34633.997
Period201720182019202020212022202320242025MRQ
Shares, quarterly33.54133.54634.8935.03535.03834.34633.94633.99233.997
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,821.491,846.471,719.851,554.731,378.171,221.751,072.821,259.431,215.77
Cost of Goods Sold Incl. D&A1,419.161,420.651,294.371,201.181,051.91914.05812.53910.23880.62
Gross Profit402.33425.81425.48353.55326.26307.70260.30349.20335.15
Selling, General and Administrative Excl. Other225.30208.94193.87191.00188.88164.90157.30158.66164.23
Research and Development50.3246.3550.4458.5260.9251.9848.4746.5348.45
Other Operating Expense12.617.60-1.082.261.570.584.600.000.99
Operating Income164.42209.27232.69160.28135.81142.2398.39190.54169.93
Interest Expense38.8242.3156.3752.5437.6024.5934.2251.7786.21
Unusual Expense17.86-5.7323.277.5215.1111.06-21.9437.0227.66
Net Income Before Taxes107.96125.40147.56105.3875.96101.0686.21105.1961.12
Income Taxes4.2622.5726.5116.2410.618.048.9513.9714.08
Consolidated Net Income103.70102.83121.0589.1465.3593.0277.2691.2247.03
Net Income From Continuing Operations103.70102.83121.0589.1465.3593.0277.2691.2247.03
Net Income103.70102.76120.7290.6565.3593.0277.2691.36-27.00
EPS (Recurring)3.362.783.842.842.283.031.873.55-0.24
EPS (Basic, Before Extraordinaries)3.012.963.592.721.972.822.352.80-0.84
EPS (Diluted)2.992.893.392.721.962.802.332.77-0.84
EBITDA303.82335.22339.82255.91237.65231.83185.53268.43251.46
Non-Operating Income (Expense)0.23-47.29-5.485.16-7.14-5.510.103.455.06
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense17.2015.7919.6719.6218.1111.826.696.788.27
Price To Earnings Ratio42.4042.4041.0140.9633.4130.6034.7929.0814.74
Price To Sales Ratio2.401.512.752.151.662.332.512.112.01
Gross Margin22.0923.0624.7422.7423.6725.1924.2627.7327.57
Operating Margin9.0311.3313.5310.319.8511.649.1715.1313.98
Net Margin5.695.577.025.834.747.617.207.25-2.22
Shares Outstanding34.0034.3533.5533.3333.1733.0632.9132.7032.47
Market Capitalization4,304.744,304.744,444.993,302.012,268.152,826.092,669.142,628.372,469.53

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue449.62459.88441.10470.89466.57472.83436.17452.03
Cost of Goods Sold Incl. D&A358.18362.26333.93364.80358.28365.54330.24338.12
Gross Profit91.4497.62107.17106.10108.29107.29105.93113.92
Selling, General and Administrative Excl. Other54.3355.3361.8553.7948.5754.4553.9248.33
Research and Development13.1310.9916.0910.1110.9514.2414.2010.61
Other Operating Expense3.587.200.631.206.120.130.33-0.08
Operating Income33.5335.0944.6951.1153.6052.7051.6765.67
Interest Expense9.7010.139.739.259.379.6214.0713.23
Unusual Expense7.042.849.79-1.81-0.16-5.501.577.03
Net Income Before Taxes17.5123.2920.3546.8145.9945.60-13.0039.26
Income Taxes2.53-0.313.85-1.806.318.599.476.29
Consolidated Net Income14.9823.6116.5148.6139.6837.01-22.4632.97
Net Income From Continuing Operations14.9823.6116.5148.6139.6837.01-22.4632.97
Net Income14.9823.6116.5148.6139.6837.01-22.5332.70
EPS (Recurring)0.580.750.681.351.110.93-0.631.04
EPS (Basic, Before Extraordinaries)0.440.690.481.391.131.06-0.660.97
EPS (Diluted)0.430.690.481.381.111.04-0.660.90
EBITDA67.8869.6279.7086.6286.6484.9981.5194.59
Non-Operating Income (Expense)0.731.18-4.823.141.60-2.99-49.04-6.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.134.255.263.553.904.475.444.67
Price To Earnings Ratio42.4023.2930.6732.8445.6358.3535.1441.01
Price To Sales Ratio2.401.771.621.491.982.442.262.77
Gross Margin20.3421.2324.3022.5323.2122.6924.2925.20
Operating Margin7.467.6310.1310.8511.4911.1511.8514.53
Net Margin3.335.133.7410.328.507.83-5.177.23
Shares Outstanding34.0033.9933.9534.3535.0435.0334.8933.55
Market Capitalization4,304.743,173.083,027.852,748.063,620.154,290.673,967.194,444.99

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments17.1646.5423.6724.2717.8949.2113.5425.5737.34
Short Term Receivables458.62349.04317.15298.25251.79198.51216.75185.50194.84
Inventories253.74247.13229.10208.77155.70149.32167.26190.08176.74
Other Current Assets40.5728.4147.7427.0027.6115.9017.8515.10122.98
Total Current Assets770.10671.12617.67558.30452.98412.94415.39416.25531.91
Net Property, Plant & Equipment671.97579.57485.56400.90347.15299.12288.56231.27235.18
Total Investments and Advances7.967.428.2013.8921.8327.1922.2626.9920.81
Intangible Assets1,936.341,796.021,773.611,802.081,732.511,616.671,615.401,644.681,702.74
Deferred Tax Assets8.998.317.006.255.714.404.443.943.45
Other Assets15.2115.5450.6212.9722.0311.557.043.56354.25
Total Assets3,410.583,077.972,942.652,794.392,582.222,371.862,353.092,326.682,848.34
Short Term Debt Incl. Current Port. of LT Debt22.1125.6610.9429.6425.1145.9345.0137.5030.47
Accounts Payable113.13101.50118.26110.7876.8651.5764.9757.1964.55
Income Tax Payable3.252.983.9010.920.721.853.0210.126.76
Other Current Liabilities93.5697.0487.8872.4156.9356.8466.0759.76107.22
Total Current Liabilities232.04227.17220.97223.75159.63156.19179.08164.57209.00
Long Term Debt1,295.661,081.621,042.32979.13872.64731.62814.39888.011,578.70
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities116.33124.61143.55160.67171.50182.30187.98203.91140.96
Other Liabilities19.9125.3616.7713.3823.7430.6919.169.7026.30
Total Liabilities1,663.931,458.761,423.611,376.931,227.521,100.801,200.611,266.191,954.96
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,746.641,619.211,519.041,417.461,354.701,271.061,152.491,060.49893.38
Total Shareholders Equity1,746.641,619.211,519.041,417.461,354.701,271.061,152.491,060.49893.38
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,746.641,619.211,519.041,417.461,354.701,271.061,152.491,060.49893.38
Total Liabilities & Stockholders Equity3,410.583,077.972,942.652,794.392,582.222,371.862,353.092,326.682,848.34
Book Value Per Share50.8548.2745.5842.7340.9738.6235.2432.6628.03
Tangible Book Value Per Share-5.52-5.27-7.64-11.60-11.43-10.50-14.16-17.99-25.39
Full-Time Employees11,00011,00010,50010,0009,0007,5008,2508,2509,700
Price to Book Ratio2.492.742.261.672.092.102.282.341.74
Return on Assets3.174.023.112.433.763.273.901.823.07
Return on Equity6.117.716.074.717.096.388.244.8110.76
Return on Invested Capital3.384.473.542.734.183.864.65-1.392.70
Quick Ratio2.231.871.761.561.861.691.391.371.70
Current Ratio3.322.952.802.502.842.642.322.532.54

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income103.70102.81119.9090.6566.3896.8177.2696.34167.96
Depreciation134.69125.95107.1395.62102.9189.6087.1377.8988.99
Other Funds (Non Cash)54.5290.5046.9155.7340.4428.277.7541.54-172.85
Funds from Operations286.15316.57259.83232.51192.23204.41165.18205.49145.23
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-109.68-120.42-54.62-52.30-75.85-47.7416.16-40.13-9.92
Income Taxes Payable-7.08-4.850.81-7.4912.52-4.12-4.34-4.960.21
Cash from Operating Activities176.48196.15205.21180.21116.38156.67181.34165.36135.31
Capital Expenditures-94.66-91.03-105.61-119.94-74.73-53.46-51.44-63.21-44.91
Net Assets From Acquisitions-8.00-178.87-138.54-43.60-126.64-217.98-5.22-0.00
Sale of Fixed Assets and Businesses0.000.000.040.170.640.440.080.03582.81
Purchase or Sale of Investments-14.040.000.000.000.300.000.00-0.42-1.23
Purchase of Investments-14.040.000.000.000.000.000.00-0.42-1.23
Sale Or Maturity of Investments0.000.000.000.000.300.000.000.000.00
Other Uses0.00-0.950.000.000.000.000.000.000.00
Other Sources0.130.1248.700.000.000.000.004.730.00
Cash from Investing Activities-116.57-270.73-195.41-163.37-200.42-271.00-56.58-58.86536.67
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-100.01-46.370.742.300.150.743.263.2412.41
Repurchase of Common Pref Stock-100.01-50.010.000.000.000.000.000.000.00
Sale of Common Pref Stock0.003.640.742.300.150.743.263.2412.41
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net11.63176.4823.52-9.5694.9187.46-88.02-117.89-700.47
Change in Long Term Debt11.63176.4823.52-9.5694.9187.46-88.02-117.89-700.47
Issuance of Long Term Debt226.961,283.11281.75832.36166.00892.41184.4932.625.00
Reduction of Long Term Debt-215.33-1,106.63-258.23-841.92-71.09-804.96-272.51-150.50-705.47
Net Financing Active Other Cash Flow-15.52-86.55-10.94-10.76-2.58-6.21-3.82-3.28-5.03
Other Financing Activities Uses-15.69-87.92-10.94-10.76-3.90-6.21-3.82-3.28-5.03
Cash from Financing Activities-103.9043.5613.32-18.0192.4881.99-88.58-117.93-693.09
Exchange Rate Effect-0.821.64-0.240.57-2.051.02-0.52-0.602.58
Net Change in Cash-44.81-29.3822.87-0.606.39-31.3235.67-12.03-18.53
Free Cash Flow81.82105.1299.8560.2741.65103.20134.51117.1690.40
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow53.4826.5647.3155.4954.8227.5819.9922.6827.03
Deferred Taxes & Investment Tax Credit--2.69-14.11-9.49-17.50-10.27-6.97-10.2961.13

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments14.1321.388.1217.1658.9423.14
Short Term Receivables464.37457.75443.50458.62417.27405.49
Inventories278.59288.06284.48253.74263.54266.44
Other Current Assets44.3043.4538.6740.5738.3742.37
Total Current Assets801.39810.63774.76770.10778.12737.43
Net Property, Plant & Equipment673.21671.34675.31671.97648.67644.41
Total Investments and Advances6.4520.1420.237.967.647.51
Intangible Assets1,870.891,893.491,913.101,936.341,936.521,954.92
Deferred Tax Assets8.949.018.988.998.548.52
Other Assets33.0618.9719.3315.2117.8218.15
Total Assets3,393.943,423.603,411.723,410.583,397.313,370.93
Short Term Debt Incl. Current Port. of LT Debt8.368.218.1122.119.128.92
Accounts Payable111.00111.85115.00113.13110.74117.37
Income Tax Payable---3.25--
Other Current Liabilities81.7697.0883.2393.5689.9589.74
Total Current Liabilities201.12217.14206.34232.04209.82216.03
Long Term Debt1,336.191,356.321,373.351,295.661,302.031,312.19
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities113.60114.75115.10116.33114.70114.73
Other Liabilities16.6216.6420.0419.9124.9324.45
Total Liabilities1,667.541,704.851,714.831,663.931,651.471,667.40
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,726.401,718.751,696.891,746.641,745.841,703.54
Total Shareholders Equity1,726.401,718.751,696.891,746.641,745.841,703.54
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,726.401,718.751,696.891,746.641,745.841,703.54
Total Liabilities & Stockholders Equity3,393.943,423.603,411.723,410.583,397.313,370.93
Book Value Per Share50.7850.5649.9950.8549.8348.62
Tangible Book Value Per Share-4.25-5.14-6.37-5.52-5.44-7.18
Full-Time Employees---11,000--
Price to Book Ratio2.491.871.731.572.132.67
Return on Assets3.053.784.233.172.662.58
Return on Equity5.977.508.586.115.185.15
Return on Invested Capital0.490.770.541.601.301.23
Quick Ratio2.602.412.382.232.452.18
Current Ratio3.983.733.753.323.713.41

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income14.9823.6116.5148.6139.6837.01
Depreciation34.3534.5435.0130.7933.0432.29
Other Funds (Non Cash)12.4615.4812.9213.656.3910.21
Funds from Operations61.7973.6264.4686.2879.2479.40
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-25.16-13.89-39.76-30.87-13.65-35.53
Income Taxes Payable-1.91-11.081.404.501.14-9.30
Cash from Operating Activities36.6359.7324.7055.4165.5943.86
Capital Expenditures-20.53-22.69-23.96-27.48-19.34-19.00
Net Assets From Acquisitions0.000.000.00-8.000.001.08
Sale of Fixed Assets and Businesses0.00-0.060.060.000.00-0.01
Purchase or Sale of Investments0.00-0.04-14.000.000.000.00
Purchase of Investments0.00-0.04-14.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.00-0.950.00
Other Sources0.020.110.000.010.020.10
Cash from Investing Activities-20.51-22.68-37.90-35.47-20.27-17.83
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.00-50.00-50.010.003.64
Repurchase of Common Pref Stock0.000.00-50.00-50.010.000.00
Sale of Common Pref Stock0.000.000.000.000.003.64
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-22.30-17.2762.97-11.77-11.69-36.70
Change in Long Term Debt-22.30-17.2762.97-11.77-11.69-36.70
Issuance of Long Term Debt13.4095.76111.806.0043.8839.73
Reduction of Long Term Debt-35.70-113.03-48.83-17.77-55.57-76.43
Net Financing Active Other Cash Flow-0.12-6.32-9.140.070.98-2.54
Other Financing Activities Uses-0.12-6.32-9.14-0.11-0.10-2.58
Cash from Financing Activities-22.42-23.593.83-61.72-10.71-35.59
Exchange Rate Effect-0.94-0.200.33-0.011.190.98
Net Change in Cash-7.2413.26-9.05-41.7835.81-8.58
Free Cash Flow16.1037.040.7427.9446.2624.86
Price to Free Cash Flow53.4829.0129.9726.2229.7936.31

Revenue breakdown

Cardiac Rhythm Management & Neuromodulation2024: 660.61M 2025: 668.80M
Cardio And Vascular2024: 949.58M 2025: 1.11B
Other Markets2024: 106.41M 2025: 77.75M
Costa Rica2024: 124.69M 2025: 173.52M
Ireland2024: 84.41M 2025: 99.16M
Puerto Rico2024: 137.06M 2025: 131.26M
Rest Of World2024: 431.76M 2025: 469.89M
United States2024: 938.68M 2025: 979.81M
Total Electromedical & Electrotherapeutic Apparatus revenue2024: 1.72B 2025: 1.85B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.82%3.4M29.0M1.12M
2026-10-1511.19%3.2M29.0M1.05M
2026-09-309.28%3.1M33.8M988.37K
2026-09-157.61%2.6M33.8M936.18K
2026-08-317.74%2.6M33.6M857.94K
2026-08-148.50%2.9M33.6M847.76K
2026-07-3111.01%3.7M33.6M531.53K
2026-07-1512.99%4.4M33.5M540.71K
2026-06-3013.47%4.5M33.5M523.82K
2026-06-1513.89%4.5M32.7M580.77K
2026-05-2913.67%4.6M33.5M650.42K
2026-05-1512.77%4.3M33.5M744.37K
2026-04-3012.06%4.0M33.5M806.99K
2026-04-1511.47%3.9M33.7M786.16K
2026-03-3110.95%3.7M34.0M822.62K
2026-03-1311.12%3.8M34.0M787.96K
2026-02-2710.62%3.6M34.0M731.08K
2026-02-1310.49%3.6M34.0M656.25K
2026-01-308.83%3.0M34.4M679.65K
2026-01-158.71%3.0M34.4M1.05M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call45.0079.5083.800.004.7830.000.000.995-0.0490.003
call50.0074.5078.800.004.3440.000.000.994-0.0490.003
call55.0069.5073.800.003.9500.000.000.994-0.0490.003
call60.0064.5068.800.003.5920.000.000.993-0.0490.004
call65.0059.5063.800.003.2640.000.000.993-0.0490.004
call70.0054.5058.800.002.9600.000.000.992-0.0490.005
call75.0049.5053.800.002.6770.000.000.991-0.0490.005
call80.0044.5048.5046.402.3071.000.000.990-0.0490.006
call85.0039.5043.8017.182.1591.000.000.984-0.0630.008
call90.0034.5038.8016.201.9190.000.000.982-0.0620.009
call95.0029.6033.800.001.6880.000.000.979-0.0610.010
call10024.7028.8026.841.4663010.000.976-0.0600.011
call10519.6023.900.001.2710.000.000.964-0.0700.016
call11015.4018.206.700.9111.000.000.956-0.0670.019
call1159.6013.909.200.83927.000.000.936-0.0690.025
call1205.607.106.800.2983450.000.908-0.0600.033
call1250.902.101.840.1236.000.000.784-0.0480.059
call1300.000.050.040.0983,8230.000.251-0.0790.066
call1350.000.050.000.2040.000.000.088-0.0480.033
call1400.002.150.000.3090.000.000.022-0.0180.011
call1450.002.150.000.3990.000.000.018-0.0190.009
call1500.002.150.000.4830.000.000.015-0.0200.008
put45.000.002.151.552.7812.000.00-0.005-0.0440.003
put50.000.002.152.002.5132.000.00-0.006-0.0430.003
put55.000.002.150.002.2720.000.00-0.006-0.0430.003
put60.000.002.150.002.0520.000.00-0.007-0.0420.004
put65.000.002.150.001.8500.000.00-0.007-0.0420.004
put70.000.002.150.001.6620.000.00-0.008-0.0410.005
put75.000.002.150.001.4860.000.00-0.009-0.0410.005
put80.000.000.100.101.2722.000.00-0.010-0.0370.006
put85.000.000.159.801.1901.000.00-0.016-0.0500.008
put90.000.000.150.001.0400.000.00-0.018-0.0490.009
put95.000.000.150.000.8960.000.00-0.021-0.0470.010
put1000.000.150.150.7571.000.00-0.024-0.0450.012
put1050.000.200.200.6233.000.00-0.029-0.0430.014
put1100.000.200.200.4924.000.00-0.036-0.0410.016
put1150.000.200.000.3840.000.00-0.064-0.0520.026
put1200.000.200.080.2613710.00-0.102-0.0490.037
put1250.000.250.100.11231.000.00-0.228-0.0340.063
put1301.205.503.300.4360.000.00-0.749-0.0640.066
put1356.2010.508.200.6590.000.00-0.912-0.0370.032
put14011.2015.5015.500.8340.000.00-0.978-0.0030.011
put14516.2020.5018.460.9910.000.00-0.982-0.0030.009
put15021.2025.5023.301.1340.000.00-0.985-0.0040.008

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13G/ASEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-10-02SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-24SEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-153Initial statement of beneficial ownership of securities2026-10-05SEC
2026-10-153Initial statement of beneficial ownership of securities2026-10-05SEC
2026-10-148-KCurrent report2026-10-14SEC
2026-10-13SCHEDULE 13DSEC
2026-10-028-KCurrent report2026-10-02SEC
2026-09-308-KCurrent report2026-09-30SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-14DEFM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-08144Filing for proposed sale of securities under Rule 144.SEC
2026-09-03PREM14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-03SEC
2026-08-19DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-14SCHEDULE 13GSEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-07-03SEC
2026-08-04DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-048-KCurrent report2026-08-02SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-08-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09005.17M3
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030070.13K1
2026-020000
2026-010000
2025-120000
2025-11297.19K362.01K1

Institutional holders

Manager% owned
TUDOR INVESTMENT CORP ET AL148.73%
ABSOLUTE INVESTMENT ADVISERS, LLC29.41%
BlackRock, Inc.15.77%
STATE OF WISCONSIN INVESTMENT BOARD11.79%
SEI INVESTMENTS CO9.99%
Invesco Ltd.6.62%
VANGUARD PORTFOLIO MANAGEMENT LLC6.01%
NOMURA HOLDINGS INC4.58%
VANGUARD CAPITAL MANAGEMENT LLC4.51%
STATE STREET CORP4.16%

Funds

Fund% owned
Franklin Convertible Securities Fund154.62%
NYLIM MacKay Convertible Fund74.98%
iShares Convertible Bond ETF60.91%
NYLIM VP MacKay Convertible Portfolio52.11%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF43.86%
Calamos Market Neutral Income Fund39.10%
Columbia Convertible Securities Fund29.16%
Miller Convertible Bond Fund23.56%
Touchstone Funds Group Trust-Touchstone Ares Credit Opportunities Fund19.65%
BlackRock Event Driven Equity Fund14.71%

OakChart. ITGR. Cached 15 minutes.